調査レポート | • レポートコード：GIR-2104Z06362 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ジェネリック腫瘍薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ジェネリック腫瘍薬の種類別市場規模（大分子薬、小分子薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ジェネリック腫瘍薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、GlaxoSmithKline、Novartis、Merck、Celgene、Teva Pharmaceutical、Mylan、Aurobindo Pharma、Hikma Pharmaceuticals、Natco Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：大分子薬、小分子薬 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・ジェネリック腫瘍薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ジェネリック腫瘍薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ジェネリック腫瘍薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ジェネリック腫瘍薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ジェネリック腫瘍薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Generic Oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Generic Oncology Drugs size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Generic Oncology Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Generic Oncology Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Large Molecule Drugs
Small Molecule Drugs
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Pfizer
GlaxoSmithKline
Novartis
Merck
Celgene
Teva Pharmaceutical
Mylan
Aurobindo Pharma
Hikma Pharmaceuticals
Natco Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Generic Oncology Drugs
1.2 Classification of Generic Oncology Drugs by Type
1.2.1 Overview: Global Generic Oncology Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Generic Oncology Drugs Revenue Market Share by Type in 2020
1.2.3 Large Molecule Drugs
1.2.4 Small Molecule Drugs
1.3 Global Generic Oncology Drugs Market by Application
1.3.1 Overview: Global Generic Oncology Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Generic Oncology Drugs Market Size & Forecast
1.5 Global Generic Oncology Drugs Market Size and Forecast by Region
1.5.1 Global Generic Oncology Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Generic Oncology Drugs Market Size by Region, (2016-2021)
1.5.3 North America Generic Oncology Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Generic Oncology Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Generic Oncology Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Generic Oncology Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Generic Oncology Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Oncology Drugs Market Drivers
1.6.2 Generic Oncology Drugs Market Restraints
1.6.3 Generic Oncology Drugs Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Generic Oncology Drugs Product and Solutions
2.1.4 Pfizer Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Generic Oncology Drugs Product and Solutions
2.2.4 GlaxoSmithKline Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Generic Oncology Drugs Product and Solutions
2.3.4 Novartis Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Generic Oncology Drugs Product and Solutions
2.4.4 Merck Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Generic Oncology Drugs Product and Solutions
2.5.4 Celgene Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Celgene Recent Developments and Future Plans
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Generic Oncology Drugs Product and Solutions
2.6.4 Teva Pharmaceutical Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Teva Pharmaceutical Recent Developments and Future Plans
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Generic Oncology Drugs Product and Solutions
2.7.4 Mylan Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Mylan Recent Developments and Future Plans
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Generic Oncology Drugs Product and Solutions
2.8.4 Aurobindo Pharma Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Aurobindo Pharma Recent Developments and Future Plans
2.9 Hikma Pharmaceuticals
2.9.1 Hikma Pharmaceuticals Details
2.9.2 Hikma Pharmaceuticals Major Business
2.9.3 Hikma Pharmaceuticals Generic Oncology Drugs Product and Solutions
2.9.4 Hikma Pharmaceuticals Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.10 Natco Pharma
2.10.1 Natco Pharma Details
2.10.2 Natco Pharma Major Business
2.10.3 Natco Pharma Generic Oncology Drugs Product and Solutions
2.10.4 Natco Pharma Generic Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Natco Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Generic Oncology Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Generic Oncology Drugs Players Market Share
3.2.2 Top 10 Generic Oncology Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Generic Oncology Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Generic Oncology Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Generic Oncology Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Generic Oncology Drugs Revenue Market Share by Application (2016-2021)
5.2 Generic Oncology Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Generic Oncology Drugs Revenue by Type (2016-2026)
6.2 North America Generic Oncology Drugs Revenue by Application (2016-2026)
6.3 North America Generic Oncology Drugs Market Size by Country
6.3.1 North America Generic Oncology Drugs Revenue by Country (2016-2026)
6.3.2 United States Generic Oncology Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Generic Oncology Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Generic Oncology Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Generic Oncology Drugs Revenue by Type (2016-2026)
7.2 Europe Generic Oncology Drugs Revenue by Application (2016-2026)
7.3 Europe Generic Oncology Drugs Market Size by Country
7.3.1 Europe Generic Oncology Drugs Revenue by Country (2016-2026)
7.3.2 Germany Generic Oncology Drugs Market Size and Forecast (2016-2026)
7.3.3 France Generic Oncology Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Generic Oncology Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Generic Oncology Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Generic Oncology Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Generic Oncology Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Generic Oncology Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Generic Oncology Drugs Market Size by Region
8.3.1 Asia-Pacific Generic Oncology Drugs Revenue by Region (2016-2026)
8.3.2 China Generic Oncology Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Generic Oncology Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Generic Oncology Drugs Market Size and Forecast (2016-2026)
8.3.5 India Generic Oncology Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Generic Oncology Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Generic Oncology Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Generic Oncology Drugs Revenue by Type (2016-2026)
9.2 South America Generic Oncology Drugs Revenue by Application (2016-2026)
9.3 South America Generic Oncology Drugs Market Size by Country
9.3.1 South America Generic Oncology Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Generic Oncology Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Generic Oncology Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Generic Oncology Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Generic Oncology Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Generic Oncology Drugs Market Size by Country
10.3.1 Middle East & Africa Generic Oncology Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Generic Oncology Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Generic Oncology Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Generic Oncology Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Generic Oncology Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Generic Oncology Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Generic Oncology Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Generic Oncology Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Generic Oncology Drugs Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Generic Oncology Drugs Product and Solutions
Table 9. Pfizer Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Generic Oncology Drugs Product and Solutions
Table 13. GlaxoSmithKline Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Generic Oncology Drugs Product and Solutions
Table 17. Novartis Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Generic Oncology Drugs Product and Solutions
Table 21. Merck Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Celgene Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Major Business
Table 24. Celgene Generic Oncology Drugs Product and Solutions
Table 25. Celgene Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 27. Teva Pharmaceutical Major Business
Table 28. Teva Pharmaceutical Generic Oncology Drugs Product and Solutions
Table 29. Teva Pharmaceutical Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Mylan Corporate Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Generic Oncology Drugs Product and Solutions
Table 33. Mylan Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Aurobindo Pharma Major Business
Table 36. Aurobindo Pharma Generic Oncology Drugs Product and Solutions
Table 37. Aurobindo Pharma Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Hikma Pharmaceuticals Major Business
Table 40. Hikma Pharmaceuticals Generic Oncology Drugs Product and Solutions
Table 41. Hikma Pharmaceuticals Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Natco Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Natco Pharma Major Business
Table 44. Natco Pharma Generic Oncology Drugs Product and Solutions
Table 45. Natco Pharma Generic Oncology Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Generic Oncology Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Generic Oncology Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Generic Oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Generic Oncology Drugs Players Head Office, Products and Services Provided
Table 50. Generic Oncology Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Generic Oncology Drugs New Entrants and Expansion Plans
Table 52. Global Generic Oncology Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Generic Oncology Drugs Revenue Share by Type (2016-2021)
Table 54. Global Generic Oncology Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Generic Oncology Drugs Revenue by Application (2016-2021)
Table 56. Global Generic Oncology Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Generic Oncology Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Generic Oncology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Generic Oncology Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Generic Oncology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Generic Oncology Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Generic Oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Generic Oncology Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Generic Oncology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Generic Oncology Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Generic Oncology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Generic Oncology Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Generic Oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Generic Oncology Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Generic Oncology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Generic Oncology Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Generic Oncology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Generic Oncology Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Generic Oncology Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Generic Oncology Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Generic Oncology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Generic Oncology Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Generic Oncology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Generic Oncology Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Generic Oncology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Generic Oncology Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Generic Oncology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Generic Oncology Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Generic Oncology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Generic Oncology Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Generic Oncology Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Generic Oncology Drugs Picture
Figure 2. Global Generic Oncology Drugs Revenue Market Share by Type in 2020
Figure 3. Large Molecule Drugs
Figure 4. Small Molecule Drugs
Figure 5. Generic Oncology Drugs Revenue Market Share by Application in 2020
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Global Generic Oncology Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Generic Oncology Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Generic Oncology Drugs Revenue Market Share by Region (2016-2026)
Figure 12. Global Generic Oncology Drugs Revenue Market Share by Region in 2020
Figure 13. North America Generic Oncology Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Generic Oncology Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Generic Oncology Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Generic Oncology Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Generic Oncology Drugs Market Drivers
Figure 18. Generic Oncology Drugs Market Restraints
Figure 19. Generic Oncology Drugs Market Trends
Figure 20. Pfizer Recent Developments and Future Plans
Figure 21. GlaxoSmithKline Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Celgene Recent Developments and Future Plans
Figure 25. Teva Pharmaceutical Recent Developments and Future Plans
Figure 26. Mylan Recent Developments and Future Plans
Figure 27. Aurobindo Pharma Recent Developments and Future Plans
Figure 28. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 29. Natco Pharma Recent Developments and Future Plans
Figure 31. Global Generic Oncology Drugs Revenue Share by Players in 2020
Figure 32. Generic Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Generic Oncology Drugs Revenue Market Share in 2020
Figure 34. Global Top 10 Players Generic Oncology Drugs Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Generic Oncology Drugs Revenue Share by Type in 2020
Figure 37. Global Generic Oncology Drugs Market Share Forecast by Type (2021-2026)
Figure 38. Global Generic Oncology Drugs Revenue Share by Application in 2020
Figure 39. Global Generic Oncology Drugs Market Share Forecast by Application (2021-2026)
Figure 40. North America Generic Oncology Drugs Sales Market Share by Type (2016-2026)
Figure 41. North America Generic Oncology Drugs Sales Market Share by Application (2016-2026)
Figure 42. North America Generic Oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 43. United States Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Generic Oncology Drugs Sales Market Share by Type (2016-2026)
Figure 47. Europe Generic Oncology Drugs Sales Market Share by Application (2016-2026)
Figure 48. Europe Generic Oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 49. Germany Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Generic Oncology Drugs Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Generic Oncology Drugs Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Generic Oncology Drugs Revenue Market Share by Region (2016-2026)
Figure 57. China Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Generic Oncology Drugs Sales Market Share by Type (2016-2026)
Figure 64. South America Generic Oncology Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Generic Oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Generic Oncology Drugs Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Generic Oncology Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Generic Oncology Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Generic Oncology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の吸入・点鼻薬ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inhalation and Nasal Sprays Generic Drugs Market The global Inhalation and Nasal Sprays Generic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…- 世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のジェネリック腫瘍学無菌注射剤市場 2021：企業別、地域別、種類・用途別 The Generic Oncology Sterile Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の腫瘍治療薬市場規模・現状・予測（2021年-2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. Market Analysis and Insights: Global Drugs for Oncology Market The global Drugs for Oncology market size is …